Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

After having navigated the challenges as a smaller, emerging competitor to break into therapeutic markets that are dominated by larger competitors, Penumbra is now poised to be acquired by Boston ...

Ahead of an artificial intelligence conference held last April, peer reviewers considered papers written by “Carl” alongside other submissions. What the reviewers did not know was that, unlike other ...

A robot named Adam was the first of its kind to do science. Adam mimicked a biologist. After coming up with questions to ask about yeast, the machine tested those questions inside a robotic laboratory ...

All opinions, columns and letters reflect the views of the individual writer and not necessarily those of the IDS or its staffers. Whether your New Year’s resolution was to lock in this semester, ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Football fans watching TV For decades, television advertising has been a game of creativity ...

The Trump administration spent 2025 taking a sledgehammer to science, obliterating funding and reshaping agencies like the FDA and the National Institutes of Health through layoffs and restrictive new ...

A tech C.E.O. explains why A.I. probably won’t cure diseases anytime soon. Hint: You still need humans. By Kevin Roose Casey Newton and Rachel Cohn The leaders of the biggest A.I. labs argue that ...

Have you ever fantasized about going back in time to relive a moment — or change it? Maybe you’re more interested in traveling to the future where cars fly and the code to immortality has been cracked ...